Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen. - Laurent C; Flores M; Chartier L; Huet S; Bolen CR; Venstrom JM; Chassagne-Clément C; Dartigues-Cuilléres P; Charlotte F; Tesson B; Salles G; Morschhauser F; et al. (British journal of haematology, 2023)